North China Pharmaceutical Company.Ltd (SHA:600812)
China · Delayed Price · Currency is CNY 4.800
+0.040 (0.84%)
Jul 29, 2026, 3:00 PM CST
SHA:600812 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,821 | 9,242 | 9,870 | 10,120 | 10,500 | 10,385 |
Revenue Growth | -10.78% | -6.36% | -2.48% | -3.62% | 1.11% | -9.64% |
Gross Profit Gross Profit Growth | 2,744 | 2,878 | 3,138 | 3,213 | 3,437 | 3,694 |
Operating Income Operating Income Growth | 577.45 | 627.16 | 658.87 | 536.44 | 634.8 | 600.11 |
Net Income Net Income Growth | 161.04 | 183.06 | 126.99 | 4.89 | -689.23 | 18.73 |
Earnings Per Share EPS Growth | 0.09 | 0.11 | 0.07 | 0.00 | -0.40 | 0.01 |
EPS Growth | -2.28% | 44.59% | 2366.67% | - | - | -81.67% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Chemical API Chemical API Growth | 2,289 |
Chemical Drug Substance Chemical Drug Substance Growth | 4,098 |
Biological Agents Biological Agents Growth | 1,613 |
Pharmaceutical Intermediates Pharmaceutical Intermediates Growth | 384.08 |
Other Other Growth | 120.61 |
Pharmaceuticals and Other Logistics Trade Pharmaceuticals and Other Logistics Trade Growth | 633.25 |
Total Total Growth | 9,138 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,385 | 1,541 | 1,660 | 988.28 | 1,683 | 5,305 |
Total Debt Total Debt Growth | 11,237 | 11,215 | 11,450 | 11,148 | 11,049 | 13,777 |
Net Cash (Debt) Net Cash Growth | -9,852 | -9,674 | -9,790 | -10,159 | -9,366 | -8,472 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.76 | -5.65 | -5.70 | -6.23 | -5.46 | -4.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,172 | 1,177 | 1,230 | 1,024 | 1,004 | 1,050 |
Capital Expenditures CapEx Growth | -544.22 | -542.01 | -784.22 | -623.04 | -549.58 | -547.5 |
Free Cash Flow Free Cash Flow Growth | 627.68 | 634.53 | 445.35 | 401.23 | 454.81 | 502.75 |
Free Cash Flow Growth | 452.18% | 42.48% | 11.00% | -11.78% | -9.54% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.11% | 31.15% | 31.79% | 31.75% | 32.73% | 35.57% |
Operating Margin | 6.55% | 6.79% | 6.68% | 5.30% | 6.05% | 5.78% |
Pretax Margin | 3.63% | 3.87% | 3.14% | 1.57% | -5.38% | 1.30% |
Profit Margin | 1.83% | 1.98% | 1.29% | 0.05% | -6.56% | 0.18% |
FCF Margin | 7.12% | 6.87% | 4.51% | 3.96% | 4.33% | 4.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.035 | 0.035 | 0.030 | 0.010 | - | 0.060 |
Dividend Per Share Growth | 16.67% | 16.67% | 200.00% | - | - | 100.00% |
Dividend Yield | 0.74% | 0.64% | 0.59% | 0.18% | - | 0.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 50.98 | 51.83 | 69.85 | 1999.79 | - | 1092.06 |
Forward PE | - | 53.18 | 40.53 | 40.53 | 40.53 | 40.53 |
P/FCF Ratio | 13.12 | 14.95 | 19.92 | 24.37 | 24.14 | 40.68 |
PS Ratio | 0.93 | 1.03 | 0.90 | 0.97 | 1.05 | 1.97 |